🇺🇸 Dihydroartemisinin Piperaquine in United States

Dihydroartemisinin Piperaquine (Dihydroartemisinin Piperaquine) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Dihydroartemisinin Piperaquine in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Dihydroartemisinin Piperaquine approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Dihydroartemisinin Piperaquine in United States?

Stanford University is the originator. The local marketing authorisation holder may differ — check the official source linked above.